Evidence map›Paper›PMID 31585109›Full record

ArticleAmerican journal of human genetics2019

De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Collosum, Axon, Cardiac, Ocular, and Genital Defects.

Andrea Accogli, Sara Calabretta, Judith St-Onge, Nassima Boudrahem-Addour, Alexandre Dionne-Laporte, Pascal Joset, Silvia Azzarello-Burri, Anita Rauch, Joel Krier, Elizabeth Fieg and 23 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02450851 (Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02450851 recruitingnot on this map

Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network

TypeobservationalSponsorNational Human Genome Research Institute (NHGRI)Ran2015 to 2028Enrolled20,000ConditionsGenetic Disease
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Excess Wnt in neurological disease.The Biochemical journal · 2025
    Review
  5. Strabismus in Genetic Syndromes: A Review.Clinical & experimental ophthalmology · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 20 institutions in 11 countries.

Andrea AccogliDepartment of Pediatrics, Division of Pediatric Neurology, McGill University, H4A 3J1, Montreal, QC, Canada; Medical Genetics Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy; Dipartimento di Neuroscienze, Reabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili, Università degli Studi di Genova, 16132 Genova Italy.
Sara CalabrettaMontreal Clinical Research Institute, H2W 1R7 Montreal, QC, Canada.
Judith St-OngeMcGill University Health Center Research Institute, H4A 3J1, Montreal, QC, Canada.
Nassima Boudrahem-AddourMcGill University Health Center Research Institute, H4A 3J1, Montreal, QC, Canada.
Alexandre Dionne-LaporteMontreal Neurological Institute, McGill University, H3A 2B4, Montreal, QC, Canada.
Pascal JosetInstitute of Medical Genetics, University of Zurich, CH-8952 Schlieren, Switzerland.
Silvia Azzarello-BurriInstitute of Medical Genetics, University of Zurich, CH-8952 Schlieren, Switzerland.
Anita RauchInstitute of Medical Genetics, University of Zurich, CH-8952 Schlieren, Switzerland.
Joel KrierBrigham and Women's Hospital, Boston, MA 02115, USA.
Elizabeth FiegBrigham and Women's Hospital, Boston, MA 02115, USA.
Juan C PallaisBrigham and Women's Hospital, Boston, MA 02115, USA.
Undiagnosed Diseases Network
Allyn McConkie-RosellDivision of Medical Genetics, Department of Pediatrics, Duke University, Durham, NC 27707, USA.
Marie McDonaldDivision of Medical Genetics, Department of Pediatrics, Duke University, Durham, NC 27707, USA.
Sharon F FreedmanDepartment of Ophthalmology, Duke University Medical Center, Durham, NC 27710, USA.
Jean-Baptiste RivièreMcGill University Health Center Research Institute, H4A 3J1, Montreal, QC, Canada.
Joël Lafond-LapalmeMcGill University Health Center Research Institute, H4A 3J1, Montreal, QC, Canada.
Brittany N SimpsonDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Robert J HopkinDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Aurélien TrimouilleCentre Hospitalier Universitaire Bordeaux, Service de Génétique Médicale, 33076 Bordeaux, France; Laboratoire Maladies Rares: Génétique et Métabolisme, Inserm U1211, Université de Bordeaux, 33076 Bordeaux, France.
Julien Van-GilsCentre Hospitalier Universitaire Bordeaux, Service de Génétique Médicale, 33076 Bordeaux, France; Laboratoire Maladies Rares: Génétique et Métabolisme, Inserm U1211, Université de Bordeaux, 33076 Bordeaux, France.
Amber BegtrupGeneDx, Gaithersburg, MD 20877, USA.
Kirsty McWalterGeneDx, Gaithersburg, MD 20877, USA.
Heron DelphineDépartement de Génétique, Centre de Référence des Déficiences Intellectuelles de Causes Rares, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, 75013 Paris.
Boris KerenDépartement de Génétique, Centre de Référence des Déficiences Intellectuelles de Causes Rares, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, 75013 Paris.
David GenevieveDépartement de Genetique Médicale, Maladies Rares et Médecine Personnalisée, Centre de Référence Anomalies du Développement, Université Montpellier, Unité Inserm U1183, Centre Hospitalier Universitaire Montpellier, 34000 Montpellier, France.
Emanuela ArgilliDepartments of Neurology and Pediatrics, Weill Institute of Neuroscience and Institute of Human Genetics, University of California, CA 94143 San Francisco.
Elliott H SherrDepartments of Neurology and Pediatrics, Weill Institute of Neuroscience and Institute of Human Genetics, University of California, CA 94143 San Francisco.
Mariasavina SeverinoIstituto di Ricovero e Cura a Carattere Scientifico, Istituto Giannina Gaslini, 16147 Genova, Italy.
Guy A RouleauMontreal Neurological Institute, McGill University, H3A 2B4, Montreal, QC, Canada; Department of Neurology and Neurosurgery, McGill University, H3A 2B4, Montreal, QC, Canada.
Patricia T YamMontreal Clinical Research Institute, H2W 1R7 Montreal, QC, Canada.
Frédéric CharronMontreal Clinical Research Institute, H2W 1R7 Montreal, QC, Canada; Department of Medicine, University of Montreal, H3C 3J7, Montreal, QC, Canada; Department of Anatomy and Cell Biology, McGill University, H4A 3J1, Montreal, QC, Canada; Department of Experimental Medicine, McGill University, H4A 3J1, Montreal, QC, Canada. Electronic address: frederic.charron@ircm.qc.ca.
Myriam SrourDepartment of Pediatrics, Division of Pediatric Neurology, McGill University, H4A 3J1, Montreal, QC, Canada; McGill University Health Center Research Institute, H4A 3J1, Montreal, QC, Canada; Department of Neurology and Neurosurgery, McGill University, H3A 2B4, Montreal, QC, Canada. Electronic address: myriam.srour@mcgill.ca.
Brigham and Women's Hospital · USMcGill University Health Centre · CADuke University · USCincinnati Children's Hospital Medical Center · USInstitute of Human Genetics · PLMontreal Clinical Research Institute · CASorbonne Université · FRUniversité de Bordeaux · FRUniversity of California, Los Angeles · USUniversity of Zurich · CHBaylor College of Medicine · USDuke Medical Center · USGenex Systems (United States) · USHudsonAlpha Institute for Biotechnology · USInserm · FRIstituto Giannina Gaslini · ITMontreal Neurological Institute and Hospital · CAUniversity of California, San Francisco · USBaylor Genetics · USBicêtre Hospital · FR

Funding

Joint Center for Mendelian GenomicsUM1HG008900 · NHGRI · BROAD INSTITUTE, INC. · PI O'DONNELL-LURIA, ANNE, REHM, HEIDI L · 2016 to 2020
$16.5M
De novo copy number variation and gene discovery in human brain malformationsR01NS058721 · NINDS · UNIVERSITY OF CHICAGO · PI ARGILLI, EMANUELA · 2008 to 2025
$10.9M
Center for Integrated Approaches to Undiagnosed DiseasesU01HG007690 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI LOSCALZO, JOSEPH · 2014 to 2022
$10.4M
CIHR FDN334023NHGRI NIH HHS U01 HG007690NHGRI NIH HHS UM1 HG008900NINDS NIH HHS R01 NS058721
6 · The paper itself

Abstract

Cadherins constitute a family of transmembrane proteins that mediate calcium-dependent cell-cell adhesion. The extracellular domain of cadherins consists of extracellular cadherin (EC) domains, separated by calcium binding sites. The EC interacts with other cadherin molecules in cis and in trans to mechanically hold apposing cell surfaces together. CDH2 encodes N-cadherin, whose essential roles in neural development include neuronal migration and axon pathfinding. However, CDH2 has not yet been linked to a Mendelian neurodevelopmental disorder. Here, we report de novo heterozygous pathogenic variants (seven missense, two frameshift) in CDH2 in nine individuals with a syndromic neurodevelopmental disorder characterized by global developmental delay and/or intellectual disability, variable axon pathfinding defects (corpus callosum agenesis or hypoplasia, mirror movements, Duane anomaly), and ocular, cardiac, and genital anomalies. All seven missense variants (c.1057G>A [p.Asp353Asn]; c.1789G>A [p.Asp597Asn]; c.1789G>T [p.Asp597Tyr]; c.1802A>C [p.Asn601Thr]; c.1839C>G [p.Cys613Trp]; c.1880A>G [p.Asp627Gly]; c.2027A>G [p.Tyr676Cys]) result in substitution of highly conserved residues, and six of seven cluster within EC domains 4 and 5. Four of the substitutions affect the calcium-binding site in the EC4-EC5 interdomain. We show that cells expressing these variants in the EC4-EC5 domains have a defect in cell-cell adhesion; this defect includes impaired binding in trans with N-cadherin-WT expressed on apposing cells. The two frameshift variants (c.2563_2564delCT [p.Leu855Valfs

Indexed as

AxonsCadherinsCorpus CallosumEyeFrameshift MutationGenitaliaHeart Defects, CongenitalHeterozygoteHumansNeurodevelopmental DisordersCadherinsACOGcardiac defectsCDH2cell-cell adhesioncorpus callosumeye defectsgenital defectsintellectual disabilityN-cadherin

Identifiers

PMID31585109
PMCPMC6817525
OpenAlexW2977626223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.